Web-based Rehabilitation After Surgical Salvage Procedures for Wrist Osteoarthritis
Launched by KAROLINSKA INSTITUTET · Feb 3, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people recover from wrist osteoarthritis after they have surgery. Wrist osteoarthritis often happens because of past injuries, and it can cause a lot of pain. After trying other treatments like exercises or medication, some people may need surgery to relieve their pain. The trial will compare a web-based rehabilitation program, which people can do online, with traditional in-person rehabilitation sessions to see if they help patients recover just as well.
To be part of this trial, participants must be scheduled for specific types of wrist surgery and should have access to digital tools for online sessions. People with certain types of arthritis or other specific conditions may not be eligible. If you join the trial, you can expect to participate in rehabilitation activities, either through the web or in person, and share your feedback on how well you are recovering. This study aims to make rehabilitation more accessible and effective for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Planned surgery:
- • Four corner fusion (4CF)
- • Lunate-Capitate fusion (LCF)
- • Scaphoid-Trapezium-Trapezoid fusion (STT)
- • Radius-Scaphoid-Lunate fusion (RSL)
- • Proximal Row Carpectomy (PRC)
- • Access to digital identification.
- Exclusion Criteria:
- • Unstable rheumatoid arthritis or other chronic inflammatory arthritis. However, stable inflammatory arthritis with unchanged medication during the last 12 weeks is not an exclusion criteria.
- • History of psoriasis arthritis, gout, or pseudogout affecting the hand or wrist.
- • Symptomatic OA in nearby joints.
- • Inability to co-operate with the follow-up protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction, inability to use web-based tools).
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Elin M Swärd, PhD
Principal Investigator
KI Department of Clinical Science and Education, Södersjukhuset
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported